Scholarlink

Purpose <p>Major cardiovascular surgery imposes high physiologic stress, often causing severe organ dysfunction and poor outcomes. The underlying mechanisms remain unclear. This study investigated metabolic changes induced by major cardiovascular surgery and the potential role of identified metabolic signatures in postoperative acute kidney injury (AKI).</p> Methods <p>A prospective observational study included 53 patients undergoing major cardiovascular surgery in 3 groups: cardiac surgery with cardiopulmonary bypass (CPB <i>n</i> = 33), without CPB (<i>n</i> = 10), and major vascular surgery (<i>n</i> = 10). For each patient, peripheral blood samples were collected pre-surgery, and at 6&#xa0;h and 24&#xa0;h post-surgery. Untargeted metabolomics using mass spectrometry quantified 8668 metabolic features in serum samples. Linear mixed-effect models (adjusted for age, sex, and body mass index) and pathway analyses were performed.</p> Results <p>In the cardiac surgery with CPB group, 772 features were significantly altered (<i>P</i> &lt; 2.8<i>E </i>– 05) across the 3 time points. These features were enriched in five classes, all related to protein metabolism, with glycine and serine metabolism being the most represented. Cardiac surgery with CPB showed a distinct metabolic signature compared to other groups. Patients who developed postoperative AKI exhibited increased protein catabolism (including valine, leucine, and isoleucine degradation), disruptions in the citric acid cycle, and plasmatic accumulation of acylcarnitines.</p> Conclusion <p>Major cardiovascular surgery, particularly with CPB, induces significant changes in protein metabolism. Patients developing postoperative AKI exhibited specific metabolic signatures. These findings may be critical for designing interventions to minimize organ dysfunction, including AKI, and improve outcomes in major cardiovascular surgery.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Role of major cardiovascular surgery-induced metabolic reprogramming in acute kidney injury in critical care

  • 期刊论文

  • 发表日期：

    2025年1月27日

查看全文
  • Tiago R. Velho,
  • Francisco Pinto,
  • Ricardo Ferreira,
  • Rafael Maniés Pereira,
  • António Duarte,
  • Makoto Harada,
  • Katharina Willmann,
  • Dora Pedroso,
  • Tiago Paixão,
  • Nuno Carvalho Guerra,
  • Ana Neves-Costa,
  • Isa Santos,
  • Ryan Gouveia e Melo,
  • Dulce Brito,
  • Ana G. Almeida,
  • Ângelo Nobre,
  • Rui Wang-Sattler,
  • Thomas Köcher,
  • Luís Mendes Pedro,
  • Fausto Pinto,
  • Luís Ferreira Moita

摘要

Purpose

Major cardiovascular surgery imposes high physiologic stress, often causing severe organ dysfunction and poor outcomes. The underlying mechanisms remain unclear. This study investigated metabolic changes induced by major cardiovascular surgery and the potential role of identified metabolic signatures in postoperative acute kidney injury (AKI).

Methods

A prospective observational study included 53 patients undergoing major cardiovascular surgery in 3 groups: cardiac surgery with cardiopulmonary bypass (CPB n = 33), without CPB (n = 10), and major vascular surgery (n = 10). For each patient, peripheral blood samples were collected pre-surgery, and at 6 h and 24 h post-surgery. Untargeted metabolomics using mass spectrometry quantified 8668 metabolic features in serum samples. Linear mixed-effect models (adjusted for age, sex, and body mass index) and pathway analyses were performed.

Results

In the cardiac surgery with CPB group, 772 features were significantly altered (P < 2.8E – 05) across the 3 time points. These features were enriched in five classes, all related to protein metabolism, with glycine and serine metabolism being the most represented. Cardiac surgery with CPB showed a distinct metabolic signature compared to other groups. Patients who developed postoperative AKI exhibited increased protein catabolism (including valine, leucine, and isoleucine degradation), disruptions in the citric acid cycle, and plasmatic accumulation of acylcarnitines.

Conclusion

Major cardiovascular surgery, particularly with CPB, induces significant changes in protein metabolism. Patients developing postoperative AKI exhibited specific metabolic signatures. These findings may be critical for designing interventions to minimize organ dysfunction, including AKI, and improve outcomes in major cardiovascular surgery.